“Increased Plasma Lipocalin-2 Levels Correlate With Disease Severity and May Be a Marker of Acute Inflammatory Response in Patients With Psoriasis”. Dermatology Reports, vol. 14, no. 4, Nov. 2022, https://doi.org/10.4081/dr.2022.9469.